Currently, a growing body of evidence demonstrates that Foxo3 aberrantly expresses in several cancers, including breast cancer [31], lung cancer [12], and esophageal squamous cell cancer progression [10]. Here, FOXO3 is linked to esophageal squamous cell carcinoma.